1. Home
  2. TCX vs KZIA Comparison

TCX vs KZIA Comparison

Compare TCX & KZIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tucows Inc.

TCX

Tucows Inc.

HOLD

Current Price

$11.89

Market Cap

167.0M

Sector

Technology

ML Signal

HOLD

Logo Kazia Therapeutics Limited

KZIA

Kazia Therapeutics Limited

BUY

Current Price

$7.90

Market Cap

186.7M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
TCX
KZIA
Founded
1992
1994
Country
Canada
Australia
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
167.0M
186.7M
IPO Year
2005
2002

Fundamental Metrics

Financial Performance
Metric
TCX
KZIA
Price
$11.89
$7.90
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
★ $28.33
AVG Volume (30 Days)
67.4K
★ 229.9K
Earning Date
11-05-2026
11-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $362,275,000.00
N/A
Revenue This Year
$26.83
N/A
Revenue Next Year
$10.04
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 6.76
N/A
52 Week Low
$8.45
$4.86
52 Week High
$25.17
$17.40

Technical Indicators

Market Signals
Indicator
TCX
KZIA
Relative Strength Index (RSI) 65.27 37.13
Support Level $8.56 $6.72
Resistance Level $15.69 $8.18
Average True Range (ATR) 0.89 0.68
MACD 0.29 0.09
Stochastic Oscillator 91.67 40.26

Price Performance

Historical Comparison
TCX
KZIA

About TCX Tucows Inc.

Tucows Inc is a corporate parent, allocating capital and providing efficient shared services to its three businesses. The Company offers Mobile Service Enabler (MSE) solutions, as well as professional services to other retail mobile providers. The Company is also a distributor of Internet services, including domain name registration, digital certificates, and email. It provides these services through an Internet-based distribution network of Internet Service Providers, web hosting companies, and other providers of Internet services to end-users. It operates in three segments: Ting, Wavelo, and Tucows Domains. It generates the majority of its revenue from Tucows Domains. The company generates key revenue from Canada and USA.

About KZIA Kazia Therapeutics Limited

Kazia Therapeutics Ltd is a biotechnology company focused on pharmaceutical drug development in oncology. The company has a portfolio of development candidates across various technologies targeting multiple cancer indications. Its primary program is Paxalisib, an investigational brain-penetrant inhibitor of the PI3K/Akt/mTOR pathway, designed for the treatment of brain cancer. The company develops targeted therapies aimed at addressing medical needs in oncology. The company operates in Australia and the United States.

Share on Social Networks: